İndosiyanin Yeşili Anjiyografi

Flower RW, Hochheimer BF. Clinical infrared absorption angiography of the choroid. Am J Ophthalmol. 1972;73:458–9.

Cohen SY, Dubois L, Quentel G, et al. Is indocyanine green angiography still relevant? Retina 2011;31:209–21.

Ott P. Hepatic elimination of indocyanine green with special reference to distribution kinetics and the influence of plasma protein binding. Pharmacol Toxicol 1998;83(2):1–48.

Lutty GA. The acute intravenous toxicity of biological stains, dyes, and other fluorescent substances. Toxicol Appl Pharmacol 1978;44:225–49.

Bischoff PM, Flower RW. Ten years experience with choroidal angiography using indocyanine green dye: a new routine examination or an epilogue? Doc Ophthalmol 1985;60:235–91.

Geeraets WJ, Berry ER. Ocular spectral characteristics as related to hazards from lasers and other light sources. Am J Ophthalmol 1968;66:15–20.

Caesar J, Shaldon S, Chiandussi L, et al. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961;21:43–57.

Leevy CM, Bender J. Physiology of dye extraction by the liver: comparative studies of sulfobromophtthalein and indocyanine green. Ann N Y Acad Sci 1963;111:161–76.

Costa DL, Huang SJ, Orlock DA, et al. Retinal-choroidal indocyanine green dye clearance and liver dysfunction. Retina 2003;23:557–61.

Hope-Ross M, Yannuzzi LA, Gragoudas ES, et al. Adverse reactions due to indocyanine green. Ophthalmology 1994;101:529–33.

Speich R, Saesseli B, Hoffmann U, et al. Anaphylactoid reactions after indocyanine-green administration. Ann Intern Med 1988;109:345–6.

Benya R, Quintana J, Brundage B. Adverse reactions to indocyanine green: a case report and a review of the literature. Cathet Cardiovasc Diagn 1989;17:231–3.

Iseki K, Onoyama K, Fujimi S, et al. Shock caused by indocyanine green dye in chronic hemodialysis patients. Clin Nephrol 1980;14:210.

Flower RW, Csaky KG, Murphy RP. Disparity between fundus camera and scanning laser ophthalmoscope indocyanine green imaging of retinal pigment epithelium detachments. Retina 1998;18:260–8.

Wolf S, Wald KJ, Elsner AE, et al. Indocyanine green choroidal videoangiography: a comparison of imaging analysis with the scanning laser ophthalmoscope and the fundus camera. Retina 1993;13:266–9.

Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology 2003;110:15–21;quiz 22–3.

Yannuzzi LA, Flower RW, Slakter JS. Indocyanine green angiography. St Louis: Mosby Year Book; 1997: 46.

Hayreh SS. Physiological anatomy of the choroidal vascular bed. Int Ophthalmol 1983;6:85–93.

Mutoh T, Sakurai M, Tamai M. Indocyanine green fundus angiography of retrobulbar vasculature. Arch Ophthalmol 1995;113:631–3.

Ohno-Matsui K, Morishima N, Ito M, et al. Indocyanine green angiography of retrobulbar vascular structures in severe myopia. Am J Ophthalmol 1997;123:494–505.

Gass JD. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 1994;118:285–98.

Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol 1991;109:1242–57.

Sadda SR, Liakopoulos S, Keane PA, et al. Relationship between angiographic and optical coherence tomographic (OCT) parameters for quantifying choroidal neovascular lesions. Graefes Arch Clin Exp Ophthalmol 2010;248:175–84.

Freund KB, Ho IV, Barbazetto IA, et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 2008;28: 201–11.

Olsen TW, Feng X, Kasper TJ, et al. Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration. Ophthalmology 2004;111:250–5.

Guyer DR, Yannuzzi LA, Slakter JS, et al. Classi cation of choroidal neovascularization by digital indocyanine green videoangiography. Ophthalmology 1996;103:2054–60.

Yannuzzi LA, Hope-Ross M, Slakter JS, et al. Analysis of vascularized pigment epithelial detachments using indocyanine green videoangiography. Retina 1994;14:99–113.

Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age- related macular degeneration. N Engl J Med 2006;355:1419–31.

Massacesi AL, Sacchi L, Bergamini F, et al. The prevalence of retinal angio- matous proliferation in age-related macular degeneration with occult choroi- dal neovascularization. Graefes Arch Clin Exp Ophthalmol 2008;246:89–92.

Shiraga F, Ojima Y, Matsuo T, et al. Feeder vessel photocoagulation of subfo- veal choroidal neovascularization secondary to age-related macular degenera- tion. Ophthalmology 1998;105:662–9.

Staurenghi G, Orzalesi N, La Capria A, et al. Laser treatment of feeder vessels in subfoveal choroidal neovascular membranes: a revisitation using dynamic indocyanine green angiography. Ophthalmology 1998;105:2297–305.

Bottoni F, Massacesi A, Cigada M, et al. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 2005;123:1644–50.

Schmidt-Erfurth U, Kriechbaum K, Oldag A. Three-dimensional angiography of classic and occult lesion types in choroidal neovascularization. Invest Ophthalmol Vis Sci 2007;48:1751–60.

Watzke RC, Klein ML, Hiner CJ, et al. A comparison of stereoscopic fluorescein angiography with indocyanine green videoangiography in age-related macular degeneration. Ophthalmology 2000;107:1601–6.

Hlushchuk R, Baum O, Gruber G, et al. The synergistic action of a VEGF-receptor tyrosine-kinase inhibitor and a sensitizing PDGF-receptor blocker depends upon the stage of vascular maturation. Microcirculation 2007;14:813–25.

Massacesi AL, Sacchi L, Bergamini F, et al. The prevalence of retinal angiomatous proliferation in age-related macular degeneration with occult choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 2008;246:89–92.

Hartnett ME, Weiter JJ, Staurenghi G, et al. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 1996;103:2042–53.

Massacesi AL, Sacchi L, Bergamini F, et al. The prevalence of retinal angiomatous proliferation in age-related macular degeneration with occult choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 2008;246:89–92.

Viola F, Massacesi A, Orzalesi N, et al. Retinal angiomatous proliferation: natural history and progression of visual loss. Retina 2009;29:732–9.

Rouvas AA, Papakostas TD, Vavvas D, et al. Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. Retina 2009;29:536–44.

Saito M, Shiragami C, Shiraga F, et al. Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 2010;149:472–81.

Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990;10:1–8.

Spaide RF, Yannuzzi LA, Slakter JS, et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995;15:100–10.

Yannuzzi LA, Wong DW, Sforzolini BS, et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 1999;117:1503–10.

Ahuja RM, Stanga PE, Vingerling JR, et al. Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments. Br J Ophthalmol 2000;84:479–84.

Ahuja RM, Downes SM, Stanga PE, et al. Polypoidal choroidal vasculopathy and central serous chorioretinopathy. Ophthalmology 2001;108:1009–10.

Yannuzzi LA, Freund KB, Goldbaum M, et al. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology 2000;107:767–77.

Maruko I, Iida T, Saito M, et al. Combined cases of polypoidal choroidal vasculopathy and typical age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2010;248:361–8.

Lai TY, Chan WM, Liu DT, et al. Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy. Br J Ophthalmol 2008;92:661–6.

Eandi CM, Ober MD, Freund KB, et al. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization. Retina 2007;27:825–31.

Guyer DR, Yannuzzi LA, Slakter JS, et al. Digital indocyanine green videoan¬giography of central serous chorioretinopathy. Arch Ophthalmol 1994;112:1057–62.

Yannuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2003;23:288–98.

Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina 1994;14:231–42.

Reibaldi M, Cardascia N, Longo A, et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonran¬domized clinical trial. Am J Ophthalmol 2010;149:307–15.

Inoue R, Sawa M, Tsujikawa M, et al. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol 2010;149:441–6.

Tsujikawa A, Ojima Y, Yamashiro K, et al. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography. Retina 2010;30:801–9.

Kitaya N, Nagaoka T, Hikichi T, et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol 2003;87:709–12.

Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996;121:26–34.

Shields JA, Shields CL. Vascular tumors and malformations of the uvea. In: Atlas of Intraocular Tumors. Philadelphia: Lippincott, Williams & Wilkins; 2008:230–51.

Mashayekhi A, Shields CL. Circumscribed choroidal hemangioma. Curr Opin Ophthalmol 2003;14:142–9.

Mantelli F, Bruscolini A, La Cava M, Abdolrahimzadeh S, Lambiase A. Ocular manifestations of Sturge-Weber syndrome: pathogenesis, diagnosis, and management. Clin Ophthalmol 2016;10:871–8.

Singh AD, Kaiser PK, Sears JE. Choroidal hemangioma. Ophthalmol Clin North Am 2005;18:151–61.

Arevalo JF, Shields CL, Shields JA, et al. Circumscribed choroidal hemangioma: characteristic features with indocyanine green videoangiography. Ophthalmology 2000;107:344–50.

Sallet G, Amoaku WM, Lafaut BA, et al. Indocyanine green angiography of choroidal tumors. Graefes Arch Clin Exp Ophthalmol 1995;233:677–89.

Andersen MV, Scherfig E, Prause JU. Differential diagnosis of choroidal melanomas and nevi using scanning laser ophthalmoscopical indocyanine green angiography. Acta Ophthalmol Scand 1995;73:453–6.

Mueller AJ, Bartsch DU, Folberg R, et al. Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol 1998;116:31–9.

Mueller AJ, Freeman WR, Schaller UC, et al. Complex microcirculation patterns detected by confocal indocyanine green angiography predict time to growth of small choroidal melanocytic tumors: MuSIC Report II. Ophthalmology 2002;109:2207–14.

Schaller UC, Mueller AJ, Bartsch DU, et al. Choroidal melanoma microcirculation with confocal indocyanine green angiography before and 1 year after radiation brachytherapy. Retina 2000;20:627–32.

Krause L, Bechrakis NE, Heinrich S, et al. Indocyanine green angiography and fluorescein angiography of malignant choroidal melanomas following proton beam irradiation. Graefes Arch Clin Exp Ophthalmol 2005;243:545–50.

Midena E, Pilotto E, de Belvis V et al. Choroidal vascular changes after transpupillary thermotherapy for choroidal melanoma. Ophthalmology 2003;110:2216–22.

Annesley WHJ. Peripheral exudative hemorrhagic chorioretinopathy. Trans Am Ophthalmol Soc 1980;78:321–64.

Shields CL, Salazar PF, Mashayekhi A, et al. Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes. Ophthalmology 2009;116:529–35.

Shields JA, Mashayekhi A, Ra S, Shields CL. Pseudomelanomas of the posterior uveal tract: the 2006 Taylor R. Smith Lecture. Retina. 2005;25(6):767-71.

Ghassemi F, Bazvand F, Hosseini SS. Pseudomelanoma at a referral center in iran. J Ophthalmic Vis Res. 2014;9(1):50–3.

Gross NE, Yannuzzi LA, Freund KB, et al. Multiple evanescent white dot syndrome. Arch Ophthalmol 2006;124:493–500.

Dell’omo R, Wong R, Marino M, et al. Relationship between different fluorescein and indocyanine green angiography features in multiple evanescent white dot syndrome. Br J Ophthalmol 2010;94:59–63.

Slakter JS, Giovannini A, Yannuzzi LA et al. Indocyanine green angiography of multifocal choroiditis. Ophthalmology 1997;104:1813–9.

Fardeau C, Herbort CP, Kullmann N, et al. Indocyanine green angiography in birdshot chorioretinopathy. Ophthalmology 1999;106:1928–34.

Trinh L, Bodaghi B, Fardeau C et al. Clinical features, treatment methods, and evolution of birdshot chorioretinopathy in 5 different families. Am J Ophthalmol 2009;147:1042–7.

Park D, Schatz H, McDonald HR, et al. Indocyanine green angiography of acute multifocal posterior placoid pigment epitheliopathy. Ophthalmology 1995;102:1877–83.

Howe LJ, Woon H, Graham EM, et al. Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiography study. Ophthalmology 1995;102:790–8.

Schneider U, Inhoffen W, Gelisken F. Indocyanine green angiography in a case of unilateral recurrent posterior acute multifocal placoid pigment epitheliopathy. Acta Ophthalmol Scand 2003;81:72–5.

Giovannini A, Mariotti C, Ripa E, et al. Indocyanine green angiographic findings in serpiginous choroidopathy. Br J Ophthalmol 1996;80:536–40.

Amer R, Lois N. Punctate inner choroidopathy. Surv Ophthalmol 2011;56:36–53.

Tiffin PA, Maini R, Roxburgh ST, et al. Indocyanine green angiography in a case of punctate inner choroidopathy. Br J Ophthalmol 1996;80:90–1.

Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol 2000;84(1):110–16.

Heiligenhaus A, Wefelmeyer D, Wefelmeyer E, et al. The eye as a common site for the early clinical manifestation of sarcoidosis. Ophthalmic Res 2011;46(1):9–12.

Letocha CE, Shields JA, Goldberg RE. Retinal changes in sarcoidosis. Can J Ophthalmol 1975;10(2):184–92.